Observational studyBMC cancer2026

Patient-reported outcomes of adjuvant therapy with CDK4/6 inhibitors for HR+/HER2- early breast cancer: a retrospective cohort study.

Binbin Cong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.